Drug Type Shared antigen vaccine, Synthetic peptide vaccine, Therapeutic vaccine |
Synonyms MAGE-12 |
Target |
Action inhibitors |
Mechanism MAGEA12 inhibitors(MAGE family member A12 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bone Cancer | Phase 1 | United States | 01 Jul 2000 | |
Breast Cancer | Phase 1 | United States | 01 Jul 2000 | |
Colonic Cancer | Phase 1 | United States | 01 Jul 2000 | |
Eye Neoplasms | Phase 1 | United States | 01 Jul 2000 | |
Lung Cancer | Phase 1 | United States | 01 Jul 2000 | |
Melanoma, Cutaneous Malignant | Phase 1 | United States | 01 Jul 2000 | |
Neoplasm Metastasis | Phase 1 | United States | 01 Jul 2000 | |
Ovarian Carcinosarcoma | Phase 1 | United States | 01 Jul 2000 | |
Rectal Cancer | Phase 1 | United States | 01 Jul 2000 | |
Soft Tissue Sarcoma | Phase 1 | United States | 01 Jul 2000 |